FDA
-
-
-
-
-
-
-
RadioMedix Appoints Brian A. Markison to Board of Directors
-
-
-
-
-
-
-
Citizens Reiterates Market Outperform Rating on Lantheus Holdings (LNTH)
-
-
-
-
-
-
-
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
-
-
-
-
-
-
-
Lantheus receives FDA PDUFA date of March 29, 2026 for NET imaging kit
-
-
-
-
-
-
-
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
-
-
-
-
-
-
-
Biotech Q4 earnings preview: Goldman Sachs
-
330,731 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

